Developer docs
API playgroundTry for free, no card

Search company profiles

Arc Medical Design

Full company profile

uuid003ghhu

Namestring
Arc Medical Design
Legal namestring
Arc Medical Design
Websiteurl
endocuff.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Arc Medical Design was a UK-based medical device company founded in 2002 that developed ENDOCUFF VISION™, a single-use mechanical adjunct for colonoscopy. The device attaches to the distal end of a colonoscope and uses a single row of flexible arms to evert and flatten colonic folds during withdrawal, with the stated goal of increasing mucosal visualization and reducing the polyp and adenoma miss rate. The technology has been validated in 12 randomized controlled trials covering more than 8,000 patients and 140 colonoscopists, with meta-analytic evidence of up to an 11% increase in adenoma detection rate (ADR), and no adverse events reported across 800+ patients tested by 70 endoscopists. The product is compatible with colonoscopes from Olympus, Fujifilm, Pentax, and Storz, and is recommended under NICE Medical Technology Guidance MTG45 for colonoscopy within the NHS in England.

In 2018, Olympus Corporation acquired Arc Medical Design, after which the ENDOCUFF VISION product line was integrated into Olympus Medical Systems' portfolio. Commercial activity is now executed through Olympus's established medical device distribution channels — including regional websites spanning Europe, the Middle East, Africa, Latin America, and the United States, the EndoTherapy online catalog, and a direct enterprise field sales force targeting hospital gastroenterology and endoscopy departments. Pricing is quote-based through Olympus representatives and is not publicly disclosed. As an absorbed unit, Arc Medical Design no longer operates as an independent entity and has no separately disclosed revenue, headcount trend, or independent funding activity.

Short descriptiontext

Arc Medical Design developed ENDOCUFF VISION™, a mechanical colonoscopy adjunct device with flexible arms; the UK firm was acquired by Olympus in 2018 and now operates as part of Olympus Medical Systems' endoscopy portfolio.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
colonoscopy device, medical device, endoscopy accessories, colorectal screening, adenoma detection
Industry2 codes
1Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
CodeHLAHADABPrimaryYes
2Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
CodeHLAHADANPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
Product category
Endoscopy Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

ENDOCUFF VISION is sold as a medical device/product through Olympus's medical systems distribution network. The product is available via product reference numbers and catalog systems.

olympus-europa.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1ENDOCUFF VISION
Description

A colonoscopy device with flexible arms that evert and flatten colonic folds to enhance mucosal visualization during endoscopic therapy.

olympus-europa.com
Core offering1 text field

Arc Medical Design developed and commercialized ENDOCUFF VISION, a single-use colonoscopy device that attaches to the distal end of a colonoscope. It uses a row of flexible arms to evert and flatten colonic folds, maximizing mucosal visualization and reducing the adenoma and polyp miss rate during colonoscopy procedures.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Increases adenoma detection rate by up to 11%
+4 more records
Product overview1 text field

Arc Medical Design offers the ENDOCUFF VISION™ colonoscopy device. This is a mechanically enhanced colonoscopy technology designed to maximize mucosal visualization during procedures. The device attaches to the distal end of a colonoscope and uses flexible arms to evert and flatten colonic folds, enhancing the viewable colonic surface and reducing polyp miss rates. The technology is backed by extensive clinical evidence from 12 randomized controlled trials with over 8,000 patients.

Product and service1 record
1ENDOCUFF VISION™
CategoryColonoscopy Enhancement Device
Description

A single-use device that attaches to the distal end of a colonoscope, featuring a row of flexible arms that evert and flatten colonic folds during colonoscopy. It is intended for use by hospital endoscopy units and gastroenterology departments to improve adenoma detection, reduce the polyp miss rate, and lower the risk of interval colorectal cancers.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major endoscopy and visualization equipment manufacturer, also a named compatibility partner for ENDOCUFF VISION. Comparable as a broad incumbent whose endoscope installed base anchors demand for compatible colonoscopy accessories.

TypeBroad incumbent
Description

Major manufacturer of flexible endoscopes and colonoscopy systems, and an explicit compatibility partner for ENDOCUFF VISION. Comparable as a broad incumbent colonoscope OEM whose installed base drives demand for colonoscopy adjunct devices.

TypeBroad incumbent
Description

Operates a significant GI Solutions business including GI Genius AI polyp detection and endoscopic devices. Comparable as a broad incumbent in the colonoscopy procedure stack, competing for the same endoscopy department budgets as ENDOCUFF VISION.

TypeEmerging player
Description

AI-enabled polyp detection system (GI Genius) increasingly paired with colonoscopy workflows as a complementary or substitute category to mechanical adjuncts like ENDOCUFF VISION. Comparable as an emerging technology addressing the same adenoma-miss clinical problem through software rather than hardware.

TypeBroad incumbent
Description

Manufacturer of Pentax-brand flexible endoscopes and a named compatibility partner for ENDOCUFF VISION. Comparable as a broad incumbent colonoscope OEM addressing the same gastroenterology end-customers.

TypeEmerging player
Description

Developer of AI-driven colonoscopy polyp detection and quality measurement software, positioned to compete with or complement mechanical adjunct devices like ENDOCUFF VISION. Comparable as an emerging player addressing the same adenoma detection gap through a different modality.

TypeBroad incumbent
Description

Parent company of Arc Medical Design since 2018 and global leader in flexible endoscopy systems. Operates the broad colonoscopy platform on which ENDOCUFF VISION is deployed, and controls the global distribution channel through which the product reaches hospitals.

TypeDirect peer
Description

Developer of G-EYE, a balloon-based colonoscopy enhancement device designed to improve polyp detection by flattening haustral folds during withdrawal. Directly competes with ENDOCUFF VISION in the same adjunctive colonoscopy category, with overlapping clinical claims on adenoma detection improvement.

TypeBroad incumbent
Description

Major player in endoscopy and gastroenterology with a broad portfolio of single-use endoscopic devices, including accessories used during colonoscopy. Comparable as a broad incumbent offering overlapping but wider-scope GI solutions alongside ENDOCUFF VISION's niche.

TypeDirect peer
Description

Markets EndoRings, a distal colonoscopy attachment device that similarly enhances mucosal visualization by manipulating colonic folds. Direct competitor to ENDOCUFF VISION in the same fold-manipulation adjunct category, with comparable clinical evidence positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arc Medical Design

Endoscopy Devicesendocuff.com

Arc Medical Design developed ENDOCUFF VISION™, a mechanical colonoscopy adjunct device with flexible arms; the UK firm was acquired by Olympus in 2018 and now operates as part of Olympus Medical Systems' endoscopy portfolio.

What Arc Medical Design does

Arc Medical Design was a UK-based medical device company founded in 2002 that developed ENDOCUFF VISION™, a single-use mechanical adjunct for colonoscopy. The device attaches to the distal end of a colonoscope and uses a single row of flexible arms to evert and flatten colonic folds during withdrawal, with the stated goal of increasing mucosal visualization and reducing the polyp and adenoma miss rate. The technology has been validated in 12 randomized controlled trials covering more than 8,000 patients and 140 colonoscopists, with meta-analytic evidence of up to an 11% increase in adenoma detection rate (ADR), and no adverse events reported across 800+ patients tested by 70 endoscopists. The product is compatible with colonoscopes from Olympus, Fujifilm, Pentax, and Storz, and is recommended under NICE Medical Technology Guidance MTG45 for colonoscopy within the NHS in England.

In 2018, Olympus Corporation acquired Arc Medical Design, after which the ENDOCUFF VISION product line was integrated into Olympus Medical Systems' portfolio. Commercial activity is now executed through Olympus's established medical device distribution channels — including regional websites spanning Europe, the Middle East, Africa, Latin America, and the United States, the EndoTherapy online catalog, and a direct enterprise field sales force targeting hospital gastroenterology and endoscopy departments. Pricing is quote-based through Olympus representatives and is not publicly disclosed. As an absorbed unit, Arc Medical Design no longer operates as an independent entity and has no separately disclosed revenue, headcount trend, or independent funding activity.

Arc Medical Design firmographics

Firmographics
Name
Arc Medical Design
Legal name
Arc Medical Design
Website
https://endocuff.com
Company type
Private
Founded year
2002
Operating status
Acquired
Headcount range
1–10 employees
Short description
Arc Medical Design developed ENDOCUFF VISION™, a mechanical colonoscopy adjunct device with flexible arms; the UK firm was acquired by Olympus in 2018 and now operates as part of Olympus Medical Systems' endoscopy portfolio.
Ownership category
akta.pro rank

Arc Medical Design industry classification

Industry
Product category
Endoscopy Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
akta.pro primary industry
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)
akta.pro secondary industry
Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

  • Colonoscopy device
  • Medical device
  • Endoscopy accessories
  • Colorectal screening
  • Adenoma detection

Where Arc Medical Design is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Arc Medical Design business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel

Revenue model

  1. Medical Device Sales: ENDOCUFF VISION is sold as a medical device/product through Olympus's medical systems distribution network. The product is available via product reference numbers and catalog systems.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Arc Medical Design product offering

Product offering

Core offering

Arc Medical Design developed and commercialized ENDOCUFF VISION, a single-use colonoscopy device that attaches to the distal end of a colonoscope. It uses a row of flexible arms to evert and flatten colonic folds, maximizing mucosal visualization and reducing the adenoma and polyp miss rate during colonoscopy procedures.

Product overview

Arc Medical Design offers the ENDOCUFF VISION™ colonoscopy device. This is a mechanically enhanced colonoscopy technology designed to maximize mucosal visualization during procedures. The device attaches to the distal end of a colonoscope and uses flexible arms to evert and flatten colonic folds, enhancing the viewable colonic surface and reducing polyp miss rates. The technology is backed by extensive clinical evidence from 12 randomized controlled trials with over 8,000 patients.

Differentiator

Problem solved

Functional benefit

Brands

  • ENDOCUFF VISION: A colonoscopy device with flexible arms that evert and flatten colonic folds to enhance mucosal visualization during endoscopic therapy.

Products and services

  • ENDOCUFF VISION™ A single-use device that attaches to the distal end of a colonoscope, featuring a row of flexible arms that evert and flatten colonic folds during colonoscopy. It is intended for use by hospital endoscopy units and gastroenterology departments to improve adenoma detection, reduce the polyp miss rate, and lower the risk of interval colorectal cancers.

Quantifiable outcome

  • Increases adenoma detection rate by up to 11%
  • +4 more outcomes

Companies that use Arc Medical Design

Customer profile

Segments1 record

Ideal customer profiles1 record

Arc Medical Design technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Arc Medical Design partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves1 record

Expansion highlights3 records

Arc Medical Design competitors and assessment

Company assessment

Broad incumbents

  • Karl Storz SE & Co. KG: Major endoscopy and visualization equipment manufacturer, also a named compatibility partner for ENDOCUFF VISION. Comparable as a broad incumbent whose endoscope installed base anchors demand for compatible colonoscopy accessories.
  • Fujifilm Healthcare: Major manufacturer of flexible endoscopes and colonoscopy systems, and an explicit compatibility partner for ENDOCUFF VISION. Comparable as a broad incumbent colonoscope OEM whose installed base drives demand for colonoscopy adjunct devices.
  • Medtronic: Operates a significant GI Solutions business including GI Genius AI polyp detection and endoscopic devices. Comparable as a broad incumbent in the colonoscopy procedure stack, competing for the same endoscopy department budgets as ENDOCUFF VISION.
  • HOYA (Pentax Medical): Manufacturer of Pentax-brand flexible endoscopes and a named compatibility partner for ENDOCUFF VISION. Comparable as a broad incumbent colonoscope OEM addressing the same gastroenterology end-customers.
  • Olympus Corporation: Parent company of Arc Medical Design since 2018 and global leader in flexible endoscopy systems. Operates the broad colonoscopy platform on which ENDOCUFF VISION is deployed, and controls the global distribution channel through which the product reaches hospitals.
  • Boston Scientific: Major player in endoscopy and gastroenterology with a broad portfolio of single-use endoscopic devices, including accessories used during colonoscopy. Comparable as a broad incumbent offering overlapping but wider-scope GI solutions alongside ENDOCUFF VISION's niche.

Emerging players

  • Cosmo Pharmaceuticals (GI Genius / Medtronic): AI-enabled polyp detection system (GI Genius) increasingly paired with colonoscopy workflows as a complementary or substitute category to mechanical adjuncts like ENDOCUFF VISION. Comparable as an emerging technology addressing the same adenoma-miss clinical problem through software rather than hardware.
  • Iterative Scopes: Developer of AI-driven colonoscopy polyp detection and quality measurement software, positioned to compete with or complement mechanical adjunct devices like ENDOCUFF VISION. Comparable as an emerging player addressing the same adenoma detection gap through a different modality.

Direct peers

  • Smart Medical Systems: Developer of G-EYE, a balloon-based colonoscopy enhancement device designed to improve polyp detection by flattening haustral folds during withdrawal. Directly competes with ENDOCUFF VISION in the same adjunctive colonoscopy category, with overlapping clinical claims on adenoma detection improvement.
  • Medivators (STERIS): Markets EndoRings, a distal colonoscopy attachment device that similarly enhances mucosal visualization by manipulating colonic folds. Direct competitor to ENDOCUFF VISION in the same fold-manipulation adjunct category, with comparable clinical evidence positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Arc Medical Design social profiles

Digital presence

Arc Medical Design financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arc Medical Design leadership team

Management profile

Number of profiles

Arc Medical Design funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arc Medical Design M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arc Medical Design

What does Arc Medical Design do?

Arc Medical Design developed and commercialized ENDOCUFF VISION, a single-use colonoscopy device that attaches to the distal end of a colonoscope. It uses a row of flexible arms to evert and flatten colonic folds, maximizing mucosal visualization and reducing the adenoma and polyp miss rate during colonoscopy procedures.

Is Arc Medical Design a public or private company?

Arc Medical Design is a private company. It is classified as corporate owned and is currently acquired.

When was Arc Medical Design founded?

Arc Medical Design was founded in 2002. It employs 1 to 10 people.

Where is Arc Medical Design based?

Arc Medical Design is headquartered in London, United Kingdom, in the Europe region.

How does Arc Medical Design make money?

One revenue line is on record: medical Device Sales.

Who are Arc Medical Design's main competitors?

Broad incumbents on record are Karl Storz SE & Co. KG, Fujifilm Healthcare, Medtronic, HOYA (Pentax Medical), Olympus Corporation and Boston Scientific. Emerging players are Cosmo Pharmaceuticals (GI Genius / Medtronic) and Iterative Scopes. Direct peers are Smart Medical Systems and Medivators (STERIS).

Does Arc Medical Design have an API?

No public API is recorded for Arc Medical Design.

What industry is Arc Medical Design in?

Arc Medical Design's product category is Endoscopy Devices. Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation), with a secondary code of HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 334510.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireOlympus Subsidiary Arc Medical Settles Patent Infringement Case, Medivators to Cease Sale of AmplifEYEOlympus Corporation and Medivators announced the termination of a patent infringement lawsuit regarding Medivators' AmplifEYE products, with Medivators agreeing to cease sales after December 31, 2021. The settlement resolves legal action initiated by Olympus subsidiary Arc Medical in March 2021 over alleged infringement of two patents. Specific financial terms of the agreement remain confidential.PR NewswireOlympus announces acquisition of Arc Medical Design Limited from Norgine B.V.Olympus Corporation has signed a definitive agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V., to enhance its offerings in gastrointestinal therapeutic devices. The deal allows Olympus to take full control of the ENDOCUFF product line, improving capabilities in early detection and treatment of colorectal cancer. This acquisition aims to improve clinical outcomes and reduce costs associated with colonoscopy procedures.PR NewswireNeue und exklusive Vertriebsvereinbarung für ENDOCUFF VISION™ in Europa, dem Nahen Osten und AfrikaArc Medical Design Limited, a subsidiary of Norgine B.V., and Olympus Europa signed an exclusive distribution agreement making Olympus Europa the sole distributor of ENDOCUFF VISION across Europe, the Middle East, and Africa, with UK distribution beginning in 2019. ENDOCUFF VISION is a single-use device attached to the tip of a colonoscope that improves visualization of the colon during withdrawal and has been shown to significantly increase adenoma and colorectal cancer detection rates, raising detection rates from 36.2% to 40.9% globally. Olympus Europa will immediately begin offering ENDOCUFF VISION to customers across the EMEA region, while Norgine continues distributing the product in Australia and Olympus America handles the US and Canadian markets.PR NewswireNuevo y exclusivo acuerdo de distribución para ENDOCUFF VISION™ en Europa, Oriente Medio y ÁfricaArc Medical Design Limited, a subsidiary of Norgine B.V., has entered into a new exclusive distribution agreement with Olympus Europa for ENDOCUFF VISION in Europe, Middle East, and Africa, effective immediately, with UK distribution beginning in 2019. ENDOCUFF VISION is a single-use device that attaches to the colonoscope and has been shown to significantly improve adenoma detection rates from 36.2% to 40.9% and colorectal cancer detection during colonoscopy procedures. Olympus Europa will now offer the device across the EMEA region, joining existing distribution arrangements with Norgine in Australia and Olympus America in North America.PR NewswireENDOCUFF VISION® améliore significativement le taux de détection des adénomes et la détection du cancer colorectal durant une coloscopie chez des patients faisant l'objet d'un dépistage du cancer de lNorgine B.V. and its subsidiary Arc Medical Design Ltd announced positive results from the ADENOMA randomized controlled trial showing that ENDOCUFF VISION®-assisted colonoscopy significantly improved the adenoma detection rate from 36.2% to 40.9% (P=0.02) compared to standard colonoscopy, with the improvement driven primarily by the UK Bowel Cancer Screening Programme subgroup showing a 10.8% increase. The trial, conducted across 1,772 patients in seven UK hospitals over 16 months, also found that ENDOCUFF VISION® detected colorectal cancer in 6.6% of screening patients versus 3.7% with standard colonoscopy (P=0.03). Norgine, which holds a majority stake in Arc Medical Design Ltd, stated the device should be used systematically in colorectal cancer prevention to reduce mortality and healthcare costs.PR NewswireENDOCUFF VISION® verbessert deutlich die Adenom-Nachweisrate und die Erkennung von Darmkrebs während der Darmspiegelung bei Patienten, bei denen eine Untersuchung zur Darmkrebsfrüherkennung durchgefühNorgine B.V. and its subsidiary Arc Medical Design Ltd. announced positive results from the ADENOMA multicenter randomized controlled trial, published in the journal GUT, showing that ENDOCUFF VISION®-assisted colonoscopy increased the global adenoma detection rate from 36.2% to 40.9% (P=0.02) and detected 56 colorectal cancer cases compared to standard colonoscopy. In the UK Bowel Screening Programme subgroup specifically, adenoma detection rose by 10.8 percentage points (61.7% vs. 50.9%, p<0.001) and cancer detection improved from 3.7% to 6.6% (P=0.03) among 1,772 patients recruited across seven British hospitals over 16 months.PR NewswireArc Medical Design Ltd, filiale de Norgine, et Olympus Corporation of the Americas concluent un accord de distribution d'ENDOCUFF VISION® aux États-Unis et au CanadaNorgine B.V. and its subsidiary Arc Medical Design Ltd have entered into a distribution agreement with Olympus Corporation of the Americas, designating Olympus as the exclusive distributor of ENDOCUFF VISION® in the United States and Canada. ENDOCUFF VISION® is a medical device designed to improve visualization during endoscopic procedures such as colonoscopies, featuring articulated arms that fold during insertion and expand during withdrawal to stabilize the colonoscope and stretch mucosal surfaces. The product is currently marketed in Europe, Australia, and New Zealand through Norgine, and the agreement is expected to strengthen both companies' commercial strategies in the endoscopy sector.PR NewswireArc Medical Design Ltd, eine Tochterfirma von Norgine, schließt Vereinbarung mit Olympus Corporation of the Americas über den Vertrieb des ENDOCUFF VISION® in den USA und Kanada abNorgine B.V. and its subsidiary Arc Medical Design Ltd have entered into an exclusive distribution agreement with Olympus Corporation of the Americas for the ENDOCUFF VISION® medical device in the United States and Canada. The ENDOCUFF VISION® is a colonoscopy accessory designed to improve visualization during endoscopic procedures by stabilizing the colonoscope tip and stretching the mucosal surface during withdrawal. Financial terms of the agreement were not disclosed.PR NewswireOlympus Corporation of the Americas Enters Into US And Canada Distribution Agreement With Arc Medical Design Ltd, A Subsidiary Of Norgine For ENDOCUFF VISION®Olympus Corporation of the Americas announced on May 6, 2016 a new exclusive distribution agreement with Norgine B.V. and its subsidiary Arc Medical Design Ltd. to distribute ENDOCUFF VISION®, a second-generation single-use device designed to improve visualization during colonoscopies, in the U.S. and Canada. The product, which will be showcased at the Digestive Disease Week conference in San Diego later that month, aims to increase adenoma detection rates and reduce interval cancers. Financial terms of the agreement were not disclosed.